Odyssey Health (ODYY) Equity Average (2015 - 2026)

Odyssey Health has disclosed Equity Average across 12 years of filings, most recently posting -$10.2 million for Q2 2026.

• Quarterly Equity Average fell 8578.62% year-over-year to -$10.2 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$10.2 million (down 8578.62% YoY) and the FY2025 annual result came in at -$6.1 million, down 6.95% from the prior year.
• Equity Average declined to -$10.2 million in Q2 2026, from -$8.9 million in the prior quarter.
• Across five years, Equity Average topped out at $8.3 million in Q2 2024 and bottomed at -$10.2 million in Q2 2026.
• The 5-year median for Equity Average is -$5.2 million (2022), against an average of -$3.8 million.
• Year-over-year, Equity Average surged 247.94% in 2024 and tumbled 8578.62% in 2026.
• Odyssey Health's Equity Average stood at -$5.0 million in 2022, then slipped by 23.4% to -$6.2 million in 2023, then advanced by 6.15% to -$5.8 million in 2024, then dropped by 21.51% to -$7.1 million in 2025, then slumped by 44.19% to -$10.2 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered -$10.2 million, -$8.9 million, and -$7.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.